Cabazitaxel bụ ọgwụ a na-eji agwọ ọrịa kansa, nke so na otu ọgwụ a na-akpọ "paclitaxel analogues" ọgwụ ndị a nwere ike igbochi uto na nkewa nke mkpụrụ ndụ tumo, si otú ahụ na-ebelata ma ọ bụ gbochie ọganihu nke ọrịa cancer.
Cabazitaxel bụ ndị ọkà mmụta sayensị mbụ chọtara ya na National Cancer Institute na United States. Mgbe ọtụtụ afọ nke nyocha na mmepe, cabazitaxel aghọwo ọgwụ na-agwọ ọrịa cancer nke a na-ejikarị eme ihe na ụlọ ọgwụ. Enwere ike iji ya gwọọ ọtụtụ ọrịa cancer, gụnyere ọrịa ara ara. cancer ovarian, cancer akpa ume na-abụghị obere cell, prostate cancer, afo cancer, colon cancer, etc.
The ọgwụgwọ ụkpụrụ nkecabazitaxelbụ iji gbochie uto na mmụba nke mkpụrụ ndụ tumo site na itinye aka na usoro Mitosis ha.Kpọmkwem, cabazitaxel nwere ike ijikọta na Tubulin iji gbochie polymerization na depolymerization nke Tubulin, si otú ahụ na-emetụta usoro Mitosis nke mkpụrụ ndụ tumo, na-eme ka mkpụrụ ndụ ghara ikewa. ma na-amụba nke ọma, na-emecha na-ebute ọnwụ mkpụrụ ndụ tumo.
Cabazitaxelbụ ọgwụ dị mkpa na-egbochi ọrịa cancer nke na-enye olileanya na ohere maka ọtụtụ ndị ọrịa na-agwọ ọrịa cancer. Site na ọganihu sayensị na nkà na ụzụ na-aga n'ihu, a kwenyere na a ga-emeziwanye arụmọrụ na nchekwa nke cabazitaxel.
Ọgụgụ agbatịkwuru: Hande Biotech anọwo na-elekwasị anya na mmepụta nke paclitaxel ruo ọtụtụ afọ, ọ bụkwa ụlọ ọrụ na-emepụta onwe ya nke paclitaxel akụrụngwa maka osisi wepụ ọgwụ mgbochi ọrịa cancer nke ụlọ ọrụ nchịkwa mba dị ka US FDA, European EDQM, Australia TGA, China kwadoro. CFDA, India, Japan, wdg Yunnan Hande na-enye elu-eduCabazitaxelraw material, dị na ngwaahịa. Ọ bụrụ na ị chọrọ ha, biko nweere onwe gị ịkpọtụrụ anyị n'oge ọ bụla.
Oge nzipu: Jun-08-2023